1578301-18-4Relevant articles and documents
Design, synthesis, and evaluation of novel heteroaromatic analogs of curcumin as anti-cancer agents
Samaan, Nawras,Zhong, Qiu,Fernandez, Jayjoel,Chen, Guanglin,Hussain, Ali M.,Zheng, Shilong,Wang, Guangdi,Chen, Qiao-Hong
, p. 123 - 131 (2014)
To improve the potential of curcumin to treat advanced hormone-refractory prostate cancer, three series (A-C) of heteroaromatic analogs (thirty two compounds) with different monoketone linkers have been synthesized and evaluated for cytotoxicity against two human androgen-independent prostate cancer cell lines (PC-3 and DU-145). Among them, thirty analogs are more potent than curcumin against PC-3 cells, and twenty one analogs are more cytotoxic towards DU-145 cells relative to curcumin. The most potent compounds (44, 45, 51, and 52) also showed impressive cytotoxicity against three other metastatic cancer cell lines (MDA-MB-231, HeLa, and A549), with IC50 values ranging from 50 nM to 390 nM. All four most potent analogs exhibited no apparent cytotoxicity towards the MCF-10A normal mammary epithelial cells. Taken together, selective enhancement of cell death in prostate cancer cell lines and other aggressive cancer cell lines suggests that nitrogen-containing heteroaromatic rings are promising bioisosteres of the substituted phenyl ring in curcumin. Published by Elsevier Masson SAS.
